Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Fully equipped labs with 75-member team set-up and made operational in <100 days
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Study efficacy measures will include the expression of dystrophin protein and motor function.
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
The survey inspected ambulances operating throughout the city
Subscribe To Our Newsletter & Stay Updated